Company registration number 10671779 (England and Wales)
HEALTH INNOVATION SUPPORT LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
HEALTH INNOVATION SUPPORT LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
HEALTH INNOVATION SUPPORT LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
-
0
-
0
Tangible assets
3
102
277
Current assets
Debtors
4
1,313
8,200
Cash at bank and in hand
13,828
12,888
15,141
21,088
Creditors: amounts falling due within one year
5
(9,436)
(9,509)
Net current assets
5,705
11,579
Total assets less current liabilities
5,807
11,856
Provisions for liabilities
546
(53)
Net assets
6,353
11,803
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
6,352
11,802
Total equity
6,353
11,803

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 19 March 2026
Dr A R M McLeod
Director
Company registration number 10671779 (England and Wales)
HEALTH INNOVATION SUPPORT LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
1
Accounting policies
Company information

Health Innovation Support Limited is a private company limited by shares incorporated in England and Wales. The registered office is Isle House, Muchelney, Langport, TA10 0DP.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business. Turnover is recognised when services are provided.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

HEALTH INNOVATION SUPPORT LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 3 -
1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.7
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
HEALTH INNOVATION SUPPORT LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
3
Tangible fixed assets
Computers
£
Cost
At 1 April 2024 and 31 March 2025
2,322
Depreciation and impairment
At 1 April 2024
2,045
Depreciation charged in the year
175
At 31 March 2025
2,220
Carrying amount
At 31 March 2025
102
At 31 March 2024
277
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
750
8,200
Corporation tax recoverable
563
-
0
1,313
8,200
5
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
-
0
563
Other creditors
7,730
5,842
Accruals and deferred income
1,706
3,104
9,436
9,509
6
Related party transactions
2025
2024
Amounts due to related parties
£
£
Key management personnel
7,730
5,842
2025-03-31 2024-04-01 false false false 19 March 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Dr A R M McLeod 10671779 2024-04-01 2025-03-31 10671779 2025-03-31 10671779 2024-03-31 10671779 core:ComputerEquipment 2025-03-31 10671779 core:ComputerEquipment 2024-03-31 10671779 core:CurrentFinancialInstruments 2025-03-31 10671779 core:CurrentFinancialInstruments 2024-03-31 10671779 core:ShareCapital 2025-03-31 10671779 core:ShareCapital 2024-03-31 10671779 core:RetainedEarningsAccumulatedLosses 2025-03-31 10671779 core:RetainedEarningsAccumulatedLosses 2024-03-31 10671779 bus:Director1 2024-04-01 2025-03-31 10671779 core:ComputerEquipment 2024-04-01 2025-03-31 10671779 2023-04-01 2024-03-31 10671779 core:ComputerEquipment 2024-03-31 10671779 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10671779 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10671779 bus:FRS102 2024-04-01 2025-03-31 10671779 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 10671779 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP